RE:RE:RE:RE:Interesting, PP at 18 cents just announcedInsightful1 wrote: MedX like any company looks at opportunities and the costy of opportunities. If a strategic investor wants to put capital into MedX's tresury and that enhance MedX's balance sheet and opens up opportunities to MedX you take the money. You only do this if it speeds up your time to market. I take it that is what is behind this PP. It was done a a premium to the market which is a very good sign.
You have to stop looking at dilution as your benchmark look at the market capitalization as the benchmark it is the more relevant number. MedX could do a 20 to 1 roll-bact and that would solve the shares outstanding issue and I would highly recommend they do that once they have established a meaningful revenue base. MedX is driving to be cash flow positivethis year which is different then debt free as I am sure you are well aware.
foreshadowing.
first off, we are all investors. we own stock at a certain price. that means it is the STOCK PRICE, not the market cap that matters to us. So yes dilution matters because it means existing holders get boned. again.
and you do realize that just because you print and sell a bunch more shares (ie dilution) it doesn't automatically add to the market cap right? unless the company uses the money to improve, grow, expand, innovate (or you know do all those things you have been saying are coming around the next corner) the share price gets adjusted accordingly and the mc stays the same or drops. and these financing terms smack of total desperation. of course it was done at a "premium" when you toss it all those goodies. every broker around would take those terms and sell this to their clients who eat all the risk. a good sign? don't insult us.
and hey, what strategic investor was this financing done for? didn't see that in the news release which seems odd.
this is such a clown show.